Fierce Biotech

CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern'

CalciMedica had been evaluating the therapy, called Auxora, in the Kourage trial of patients with stage 2 or 3 AKI with ...
BioWorld

T-type calcium channel inhibitor KTt‑45 demonstrates anticancer activity in vitro

BioWorld - Friday, May 2, 2025 Breaking News: 100 days of uncertainty See today's BioWorld Science Home » T-type calcium channel inhibitor KTt‑45 demonstrates anticancer activity in vitro To read the ...
Nasdaq

CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

Preclinical data support CRAC channel inhibitor, CM5480, as a potential first-in-class, differentiated therapy for pulmonary arterial hypertension (PAH), both as monotherapy and in combination with ...
BioWorld

T-type calcium channel inhibitor KTt‑45 demonstrates anticancer activity in vitro

T-type calcium channel inhibitor KTt‑45 demonstrates anticancer activity in vitro Jan. 3, 2024 ...